Eswara Reddy along with Animesh Kumar (Assistant Drugs Inspector), Biocon Biologics' Associate Vice President L Praveen Kumar, and Synergy Network India Private Limited director Dinesh Dua, were arrested last year in the bribery case allegedly to waive the Phase 3 clinical trial of 'Insulin Aspart' injection, a product developed by the company to manage Type 1 and Type 2 diabetes. However, Biocon Biologics, a subsidiary of Kiran Mazumdar Shaw-led Biocon, denied the allegations of bribery.

Related Keywords

India , United States , Canada , Japan , New Delhi , Delhi , S Eswara Reddy , Tl Praveen Kumar , Biocon Biologics , Dinesh Dua , Guljit Sethi , Animesh Kumar , Bioinnovat Research , Union Ministry For Health , Central Drugs Standard Control Organisation , Synergy Network India Private , Biocon Biologic , Union Ministry , Family Welfare , Assistant Drugs Inspector , Synergy Network India Private Limited , Insulin Aspart , Kiran Mazumdar Shaw Led Biocon , Corruption Act , Biocon Biologicsl Praveen Kumar , Biocon , Bribery , Synergy Network , Kiran Mazumdar Shaw ,